Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs4234207 | chr3:194731909 | A/G | 9.22E-5 | 178 | 16.68 | 20.47 | 25.97 | KM Plot |
PCPG | rs4238831 | chr16:89576663 | G/A | 0.000207 | 176 | 26.78 | 25.28 | 19.53 | KM Plot |
PCPG | rs4242285 | chr6:150345084 | G/A | 1.14E-11 | 177 | 18.2 | 24.12 | 25.77 | KM Plot |
PCPG | rs4245345 | chr13:48417877 | T/C | 5.94E-5 | 177 | 2.93 | 25.17 | 25.53 | KM Plot |
PCPG | rs4257207 | chr16:89947861 | T/A | 0.000204 | 173 | 25.87 | 20.2 | 36.37 | KM Plot |
PCPG | rs4266597 | chr7:158838419 | T/C | 0.000217 | 174 | 25.53 | 19.87 | 41.87 | KM Plot |
PCPG | rs4268793 | chr17:80523106 | A/G | 4.51E-5 | 177 | 25.92 | 19.72 | 7.2 | KM Plot |
PCPG | rs427121 | chr17:3227385 | C/G | 0.000213 | 172 | 18.1 | 25.87 | 27.2 | KM Plot |
PCPG | rs4280465 | chr2:118546377 | G/A | 1.51E-5 | 178 | 24.85 | 28.8 | 11.65 | KM Plot |
PCPG | rs4285335 | chr6:156465816 | C/G | 0.000254 | 172 | 25.53 | 25.98 | 10.3 | KM Plot |
PCPG | rs4289761 | chr8:135505933 | C/T | 0.000389 | 178 | 32.03 | 25.53 | 23.88 | KM Plot |
PCPG | rs4291799 | chr13:37558968 | G/A | 0.00031 | 176 | 4.17 | 24.47 | 25.87 | KM Plot |
PCPG | rs4303422 | chr14:74578117 | G/C | 5.67E-7 | 175 | 25.4 | 27.43 | 7.4 | KM Plot |
PCPG | rs430963 | chr5:141184633 | A/G | 1.16E-6 | 178 | 23.57 | 29.57 | 24.53 | KM Plot |
PCPG | rs4345013 | chr22:27381837 | T/C | 0.000453 | 176 | 25.47 | 24.1 | 25.17 | KM Plot |